RSDTX | VBIPX | RSDTX / VBIPX | |
Total Expense Ratio | 0.50 | 0.03 | 1,667% |
Annual Report Gross Expense Ratio | 0.73 | 0.03 | 2,433% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 3.914 | 1.777 | 220% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 420M | 64.2B | 1% |
Annual Yield % from dividends | 4.17 | 3.71 | 113% |
Returns for 1 year | 4.83 | 0.59 | 825% |
Returns for 3 years | 13.83 | 2.54 | 545% |
Returns for 5 years | 7.71 | -5.36 | -144% |
Returns for 10 years | N/A | 4.22 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 21.56 | 0.41 | +1.94% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
KOMP | 55.69 | 0.96 | +1.75% |
SPDR® S&P Kensho New Economies Comps ETF | |||
APRZ | 36.22 | 0.41 | +1.15% |
TrueShares Structured Outcome April ETF | |||
MYN | 9.32 | 0.03 | +0.32% |
Blackrock Muniyield NEW York Quality Fund | |||
PCEM | 10.44 | N/A | N/A |
Polen Capital Em Mkts ex-China Gr ETF |